Kyle B Zuniga1, June M Chan2, Charles J Ryan3, Stacey A Kenfield4. 1. Osher Center for Integrative Medicine, University of California San Francisco, San Francisco, CA; College of Physicians and Surgeons, Columbia University Medical Center, New York, NY. 2. Department of Urology, University of California San Francisco, San Francisco, CA; Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA. 3. Department of Medicine, University of Minnesota, Minneapolis, MN. 4. Department of Urology, University of California San Francisco, San Francisco, CA. Electronic address: Stacey.Kenfield@ucsf.edu.
Abstract
PURPOSE: To review the literature and provide recommendations on diet and lifestyle considerations in patients with prostate cancer using evidence from randomized controlled trials (RCTs) with additional considerations based on observational evidence. MATERIALS AND METHODS: We initiated our search on ClinicalTrials.gov combining the term "prostate cancer" with a variety of diet and lifestyle factors. We then supplemented our summary of publications from registered trials by including other publications available on Pubmed. RESULTS: There is a well-established benefit of exercise for improving functional outcomes and pelvic floor muscle training for improving treatment-related adverse effects. Multimodality interventions that integrate several factors (e.g., low-saturated fat, plant-based, whole-food diets with exercise, and stress reduction) appear to have the most clinically significant benefit for patients with prostate cancer. Ongoing multimodality interventions are including the efficacy of implementation strategies as observed outcomes. Limited RCT evidence suggests a clinically significant benefit for guided imagery/progressive muscle relaxation, Pilates, and lycopene-rich diets and a modest benefit for green tea, qigong, massage, and avoidance of nonprescribed vitamin and mineral supplements. Observational and single arm trial evidence indicates a need for further exploration of acupuncture, coffee, cruciferous vegetables, fish, Larrea tridentata, mushrooms, and vegetable-derived fats and avoidance of eggs, dairy, poultry with skin, processed red meat, and saturated fat. Published trials suggest no benefit from hypnosis, milk thistle, pomegranate, soy, or omega-3 fatty acid supplementation. CONCLUSIONS: Our search demonstrated that most diet and lifestyle factors identified from observational studies have limited data from RCTs. Few items have shown early evidence of benefit. The best recommendation for patients with prostate cancer is to form a habit of wellness through healthy eating, aerobic and resistance exercise, and psychological well-being. Future trial development should consider how interventions can be implemented into real world practice.
PURPOSE: To review the literature and provide recommendations on diet and lifestyle considerations in patients with prostate cancer using evidence from randomized controlled trials (RCTs) with additional considerations based on observational evidence. MATERIALS AND METHODS: We initiated our search on ClinicalTrials.gov combining the term "prostate cancer" with a variety of diet and lifestyle factors. We then supplemented our summary of publications from registered trials by including other publications available on Pubmed. RESULTS: There is a well-established benefit of exercise for improving functional outcomes and pelvic floor muscle training for improving treatment-related adverse effects. Multimodality interventions that integrate several factors (e.g., low-saturatedfat, plant-based, whole-food diets with exercise, and stress reduction) appear to have the most clinically significant benefit for patients with prostate cancer. Ongoing multimodality interventions are including the efficacy of implementation strategies as observed outcomes. Limited RCT evidence suggests a clinically significant benefit for guided imagery/progressive muscle relaxation, Pilates, and lycopene-rich diets and a modest benefit for green tea, qigong, massage, and avoidance of nonprescribed vitamin and mineral supplements. Observational and single arm trial evidence indicates a need for further exploration of acupuncture, coffee, cruciferous vegetables, fish, Larrea tridentata, mushrooms, and vegetable-derived fats and avoidance of eggs, dairy, poultry with skin, processed red meat, and saturatedfat. Published trials suggest no benefit from hypnosis, milk thistle, pomegranate, soy, or omega-3 fatty acid supplementation. CONCLUSIONS: Our search demonstrated that most diet and lifestyle factors identified from observational studies have limited data from RCTs. Few items have shown early evidence of benefit. The best recommendation for patients with prostate cancer is to form a habit of wellness through healthy eating, aerobic and resistance exercise, and psychological well-being. Future trial development should consider how interventions can be implemented into real world practice.
Authors: Aminah Jatoi; Neil Ellison; Patrick A Burch; Jeff A Sloan; Shaker R Dakhil; Paul Novotny; Winston Tan; Tom R Fitch; Kendrith M Rowland; Charles Y F Young; Patrick J Flynn Journal: Cancer Date: 2003-03-15 Impact factor: 6.860
Authors: Aminah Jatoi; Patrick Burch; David Hillman; Joanne M Vanyo; Shaker Dakhil; Daniel Nikcevich; Kendrith Rowland; Roscoe Morton; Patrick J Flynn; Charles Young; Winston Tan Journal: Urology Date: 2007-02 Impact factor: 2.649
Authors: Tomasz M Beer; Maria Benavides; Sandra L Emmons; Margaret Hayes; Guohui Liu; Mark Garzotto; Deirdre Donovan; Nina Katovic; Caron Reeder; Kristine Eilers Journal: Urology Date: 2010-05-21 Impact factor: 2.649
Authors: Satomi Koyama; Laura J Cobb; Hemal H Mehta; Navindra P Seeram; David Heber; Allan J Pantuck; Pinchas Cohen Journal: Growth Horm IGF Res Date: 2009-10-22 Impact factor: 2.372
Authors: Amy Y Zhang; Donald R Bodner; Alex Z Fu; Douglas D Gunzler; Eric Klein; Denise Kresevic; Shirley Moore; Lee Ponsky; Michael Purdum; Gerald Strauss; Hui Zhu Journal: J Urol Date: 2015-07-29 Impact factor: 7.450
Authors: Joseph G Winger; Catherine E Mosher; Kevin L Rand; Miriam C Morey; Denise C Snyder; Wendy Demark-Wahnefried Journal: Ann Behav Med Date: 2014-10
Authors: Andrew D Frugé; John A Dasher; David Bryan; Soroush Rais-Bahrami; Wendy Demark-Wahnefried; Gary R Hunter Journal: Int J Cancer Clin Res Date: 2017-10-16
Authors: Aimee J Christie; Catherine Powers-James; Santhosshi Narayanan; Minxing Chen; Carol Eddy; Telma Gomez; Karla Crawford; Lorenzo Cohen; Gabriel Lopez Journal: Support Care Cancer Date: 2021-05-28 Impact factor: 3.603
Authors: Maria G Grammatikopoulou; Konstantinos Gkiouras; Stefanos Τ Papageorgiou; Ioannis Myrogiannis; Ioannis Mykoniatis; Theodora Papamitsou; Dimitrios P Bogdanos; Dimitrios G Goulis Journal: Nutrients Date: 2020-09-29 Impact factor: 5.717
Authors: Sara Faithfull; Jane Cockle-Hearne; Agnieszka Lemanska; Sophie Otter; Simon S Skene Journal: Support Care Cancer Date: 2021-12-21 Impact factor: 3.359
Authors: Crystal S Langlais; Rebecca E Graff; Erin L Van Blarigan; Nynikka R Palmer; Samuel L Washington; June M Chan; Stacey A Kenfield Journal: Curr Oncol Rep Date: 2021-03-10 Impact factor: 5.075